Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Published on
Journal: Brain, Behavior, & Immunity - Health
[저자] Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
[Category] update2024,
PMC URL    Pubmed URL    DOI URL    [DOI] 10.1016/j.bbih.2024.100802    
[Article Type] Full Length Article
[Source] PMC

Highlights • Schizophrenia is a risk factor for severe and fatal COVID-19 infection • Individuals with schizophrenia mounted a lower antibody response to vaccination • This may contribute to increased risk of severe breakthrough infection

All Keywords
【저자키워드】 COVID-19, immunogenicity, mRNA vaccine, Antibody Response, Schizophrenia, schizoaffective disorder,